Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Mecoli

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Journal of Scleroderma and Related Disorders|June 14, 2021
Advances at the Interface of Cancer and Systemic SclerosisChristopher A Mecoli, Antony Rosen, Livia Casciola-Rosen, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experienceChristopher A Mecoli, Deanna Saylor, Allan C Gelber, et al.
Case Reports in Rheumatology|October 2, 2018
Corrigendum to "NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation"Zeeshan Butt, Leeza Patel, Manash K Das, et al.
Case Reports in Rheumatology|July 12, 2017
NXP-2 Positive Dermatomyositis: A Unique Clinical PresentationZeeshan Butt, Leeza Patel, Manash K Das, et al.
The Journal of Rheumatology|February 16, 2022
Perifollicular Hypopigmentation in Systemic Sclerosis: Associations With Clinical Features and Internal Organ InvolvementMelody P Chung, Christopher A Mecoli, Jamie Perin, et al.
Clinical Rheumatology|May 28, 2018
Vascular complications in systemic sclerosis: a prospective cohort studyChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 23, 2020
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal AnalysisChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2017
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathiesChristopher A Mecoli, Arash H Lahouti, Robert A Brodsky, et al.
Seminars in Arthritis and Rheumatism|June 17, 2019
Evaluation of risk factors for pseudo-obstruction in systemic sclerosisEric Dein, Pei-Lun Kuo, Yun Soo Hong, et al.
Seminars in Arthritis and Rheumatism|May 2, 2026
Validity and reliability of hand-held dynamometry for proximal strength assessment in systemic sclerosis-associated myopathyJulie J Paik, Anshula Nallapati, Christopher A Mecoli, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Journal of Scleroderma and Related Disorders|June 14, 2021
Advances at the Interface of Cancer and Systemic SclerosisChristopher A Mecoli, Antony Rosen, Livia Casciola-Rosen, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experienceChristopher A Mecoli, Deanna Saylor, Allan C Gelber, et al.
Case Reports in Rheumatology|October 2, 2018
Corrigendum to "NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation"Zeeshan Butt, Leeza Patel, Manash K Das, et al.
Case Reports in Rheumatology|July 12, 2017
NXP-2 Positive Dermatomyositis: A Unique Clinical PresentationZeeshan Butt, Leeza Patel, Manash K Das, et al.
The Journal of Rheumatology|February 16, 2022
Perifollicular Hypopigmentation in Systemic Sclerosis: Associations With Clinical Features and Internal Organ InvolvementMelody P Chung, Christopher A Mecoli, Jamie Perin, et al.
Clinical Rheumatology|May 28, 2018
Vascular complications in systemic sclerosis: a prospective cohort studyChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 23, 2020
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal AnalysisChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2017
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathiesChristopher A Mecoli, Arash H Lahouti, Robert A Brodsky, et al.
Seminars in Arthritis and Rheumatism|June 17, 2019
Evaluation of risk factors for pseudo-obstruction in systemic sclerosisEric Dein, Pei-Lun Kuo, Yun Soo Hong, et al.
Seminars in Arthritis and Rheumatism|May 2, 2026
Validity and reliability of hand-held dynamometry for proximal strength assessment in systemic sclerosis-associated myopathyJulie J Paik, Anshula Nallapati, Christopher A Mecoli, et al.
Pageof 8